Highly Sensitive and Rapid Magnetic Biosensors Wendy Dittmer, Philips Research, speaking at Advances in Biodetection ad Biosensors 2012.
Capacitive Immunosensors – A Tool for Detection Where Sensitivity of Conventional ELISA is Not Sufficient Prof. Bo Mattiasson, Lund University, speaking at Advances in Biodetection and Biosensors 2012.
Antibodies and Antibody RNase Fusion Proteins Targeting CD30+ Lymphoma Thomas Schirrmann PhD, Technische Universitaet Braunschweig, speaking at BioProcessing, Biologics & Biotherapeutics Congress 2011.
Glycosylation of IgG antibodies: a Critical Quality Attribute (CQA) Professor Roy Jefferis, College of Medical and Dental Sciences, University of Birmingham, speaking at BioProcessing, Biologics & Biotherapeutics Congress 2011.
Biosimilars and the US-legislation: Analytical and Clinical Challenges Dr William Egan, Vice President in the Consulting Division of PharmaNet, speaking at BioProcessing, Biologics & Biotherapeutics Congress 2011.
Protein and Peptide Arrays for Studying Autoimmunity Professor Paul J. (P.J.) Utz, Stanford University, speaking at Microarray World Congress.
Validation of Biomarkers In Tissue Dr Stephen M. Hewitt, National Cancer Institute, speaking at Microarray World Congress 2011.
Background and Key Drivers Leading to Clinical Immunogenicity Dr Matthew Baker, Chief Scientific Officer at Antitope Ltd, speaking at Bioprocessing, Biologics and Biotherapeutics 2011.
Improving on Rituximab – Selecting CD20 mAb for the Future Professor Mark Cragg, Southampton University, speaking at BioProcessing, Biologics & Biotherapeutics Congress Europe 2011.